Home > Products > Pharmaceutical Raw Materials

Skin Lightening Cosmetic Monobenzone Powder CAS 103-16-2,4-Benzyloxyphenol

Share
Details

4-Benzyloxyphenol is a topical depigmenting agent that can decompose melanin in the skin, prevent the formation of melanin in the skin, and restore the skin to a healthy color without damaging the melanocytes, thereby achieving decolorization The role. Clinically it is mainly used to treat hyperpigmentation, such as various stains, age spots, vitiligo, melanoma, etc.

Product Name
Monobenzone
CAS
  103-16-2
Einecs No
  203-083-3
Appearance
White to off-white crystalline powder
MF
  C13H12O2
Molecular Weight
  200.23
Purity
99% 
Storage
Keep in a cool, dry, dark location in a tightly sealed container or cylinder
Shelf Life
24 Months

COA

Item
Specification
Results
Physical Property
Appearance
White to off-white crystalline Powder
Conforms
Odor
Characteristic
Conforms
General Analysis
Identification
Assay (Test by HPLC)
Loss on Drying
Identical to sample
>99%
≤1.0%
Conforms
99.98%
0.38%
Ash
≤3.0%
0.61%
Contaminants
Lead (Pb)
≤3.0mg/kg
2.2
Arsenic (As)
≤2.0mg/kg
1.6
Cadmiu (Cd)
≤1.0mg/kg
0.5
Mercur (Hg)
≤0.1mg/kg
0.06
Microbiological
Total Plate Count
≤1000cfu/g
Conforms
Yeast&Mold
≤100cfu/g
Conforms
E.Coli.
Negative
Conforms
Salmonella
Negative
Conforms


Application

4-Benzyloxyphenol is a topical depigmenting agent that can decompose melanin in the skin, prevent the formation of melanin in the skin, and restore the skin to a healthy color without damaging the melanocytes, thereby achieving decolorization The role. Clinically it is mainly used to treat hyperpigmentation, such as various stains, age spots, vitiligo, melanoma, etc.

1. Monobenzone Powder is a compound used as a topical drug for medical depigmentation.
2. The topical application of monobenzone powder in animals decreases the excretion of melanin from melanocytes. The same action is thought to be responsible for the depigmenting effect of the drug in humans.
3. Monobenzone Powder may cause destruction of melanocytes and permanent depigmentation.
4. The histology of the skin after depigmentation with topical monobenzone powder is the same as that seen in vitiligo.
5. The epidermis is normal except for the absence of identifiable melanocytes.